Storebrand Asset Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-13,254
Closed -$3.26M 871
2022
Q3
$3.26M Hold
13,254
0.02% 523
2022
Q2
$3.28M Sell
13,254
-265
-2% -$71.5K 0.02% 541
2022
Q1
$4.48M Sell
13,519
-121
-0.9% -$37.2K 0.02% 510
2021
Q4
$4.9M Sell
13,640
-1,357
-9% -$458K 0.02% 515
2021
Q3
$4.88M Sell
14,997
-421
-3% -$143K 0.02% 521
2021
Q2
$4.81M Sell
15,418
-697
-4% -$214K 0.02% 522
2021
Q1
$5.14M Hold
16,115
0.03% 507
2020
Q4
$5.22M Sell
16,115
-1,251
-7% -$346K 0.03% 469
2020
Q3
$4.81M Sell
17,366
-195
-1% -$56.2K 0.03% 434
2020
Q2
$4.24M Hold
17,561
0.04% 428
2020
Q1
$2.55M Buy
+17,561
New +$2.92M 0.03% 483

Other funds holding ABMD

Storebrand Asset Management's ABMD Position: Q4 2022 in Review

Storebrand Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 13,254 shares — an estimated $3.26M sold.

Storebrand Asset Management first reported a position in ABMD in Q1 2020 and held it in 11 quarters. The position peaked at $5.22M in Q4 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Storebrand Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Storebrand Asset Management sold 13,254 Abiomed Inc shares in Q4 2022, an estimated $3.26M.
  • Storebrand Asset Management first reported a position in Abiomed Inc in Q1 2020 and held it in 11 quarters.
  • Storebrand Asset Management's Abiomed Inc position peaked at $5.22M in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Storebrand Asset Management's 13F filing for Q4 2022, filed 18 Jun 2026.